Case report: mantle cell lymphoma, prolymphocytoid variant, with leukostasis syndrome

被引:11
作者
Smith, MD
Singleton, TP
Balaraman, S
Jaiyesimi, I
O'Malley, B
Al-Saadi, A
Mattson, JC
机构
[1] William Beaumont Hosp, Dept Clin Pathol, Royal Oak, MI 48073 USA
[2] William Beaumont Hosp, Dept Hematol Oncol, Royal Oak, MI 48073 USA
[3] William Beaumont Hosp, Dept Anat Pathol, Royal Oak, MI 48073 USA
关键词
mantle cell lymphoma; prolymphocytoid variant; leukostasis syndrome;
D O I
10.1038/modpathol.3800139
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A 76-year-old man presented with leukostasis syndrome, including oculodynia, blurred vision, and visual field defects, due to mantle cell lymphoma, prolymphocytoid variant, with marked leukocytosis, 1227 x 10(9)/l. He had splenomegaly but no lymphadenopathy or hepatomegaly. The tumor cells were CD5 +, CD19+, CD20+, FMC-7+, and kappa light chain restricted. Immunohistochemistry showed expression of p53 and of cyclin D1. Fluorescent in situ hybridization demonstrated t(11;14) with translocation between CYCLIN 01 and the immunoglobulin heavy-chain genes. The patient received leukapheresis and aggressive chemotherapy, but the leukocyte count remained above 100 x 10(9)/l. The patient's condition rapidly deteriorated with lymphomatous infiltration of his lungs and soft tissues, and he expired 6 months after diagnosis. While it is known that mantle cell lymphoma may have a leukemic phase, the degree of leukocytosis in this case exceeds that previously reported in the literature and resulted in a clinical syndrome of leukostasis.
引用
收藏
页码:879 / 883
页数:5
相关论文
共 24 条
[1]   Mantle cell lymphoma: A clinicopathologic study of 80 cases [J].
Argatoff, LH ;
Connors, JM ;
Klasa, RJ ;
Horsman, DE ;
Gascoyne, RD .
BLOOD, 1997, 89 (06) :2067-2078
[2]   New approach to classifying non-hodgkin's lymphomas: Clinical features of the major histologic subtypes [J].
Armitage, JO ;
Weisenburger, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2780-2795
[3]  
Cohen PL, 1998, BRIT J HAEMATOL, V101, P302
[4]   p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas [J].
Hernandez, L ;
Fest, T ;
Cazorla, M ;
TeruyaFeldstein, J ;
Bosch, F ;
Peinado, MA ;
Piris, MA ;
Montserrat, E ;
Cardesa, A ;
Jaffe, ES ;
Campo, E ;
Raffeld, M .
BLOOD, 1996, 87 (08) :3351-3359
[5]   CYCLINS AND CANCER .2. CYCLIN-D AND CDK INHIBITORS COME OF AGE [J].
HUNTER, T ;
PINES, J .
CELL, 1994, 79 (04) :573-582
[6]  
ICHIKAWA A, 1992, BLOOD, V79, P2701
[7]   P53 IN HEMATOLOGIC MALIGNANCIES [J].
IMAMURA, J ;
MIYOSHI, I ;
KOEFFLER, HP .
BLOOD, 1994, 84 (08) :2412-2421
[8]  
LOCOCO F, 1993, BLOOD, V82, P2289
[9]   Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation [J].
Nelson, BP ;
Variakojis, D ;
Peterson, LC .
MODERN PATHOLOGY, 2002, 15 (11) :1111-1120
[10]   Deletions and loss of expression of p16(INK4a) and p21(Waf1) genes are associated with aggressive variants of mantle cell lymphomas [J].
Pinyol, M ;
Hernandez, L ;
Cazorla, M ;
Balbin, M ;
Jares, P ;
Fernandez, PL ;
Montserrat, E ;
Cardesa, A ;
LopezOtin, C ;
Campo, E .
BLOOD, 1997, 89 (01) :272-280